Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection

Description

C-diff infection often causes belly pain and diarrhea and can be very hard to treat with medicine. One of the possible reasons that C-diff infection is hard to treat is because there is too much "bad" bacteria in the colon. Investigators believe that putting more "good" bacteria into the colon will help fight the "bad" bacteria. We do this by doing a fecal (poop) transplant. Fecal transplant has been done at other hospitals, but not at Nationwide Children's Hospital. Since our Investigators have not done this before, this study will help us learn the best way to do the transplant. Investigators also believe this transplant might help improve symptoms for patients with C-diff.

Conditions

Clostridium Difficile

Study Overview

Study Details

Study overview

C-diff infection often causes belly pain and diarrhea and can be very hard to treat with medicine. One of the possible reasons that C-diff infection is hard to treat is because there is too much "bad" bacteria in the colon. Investigators believe that putting more "good" bacteria into the colon will help fight the "bad" bacteria. We do this by doing a fecal (poop) transplant. Fecal transplant has been done at other hospitals, but not at Nationwide Children's Hospital. Since our Investigators have not done this before, this study will help us learn the best way to do the transplant. Investigators also believe this transplant might help improve symptoms for patients with C-diff.

Fecal Microbiota Transplantation (FMT) for Recurrent or Refractory C. Difficile Infection (CDI) in Pediatric and Young Adult Patients

Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection

Condition
Clostridium Difficile
Intervention / Treatment

-

Contacts and Locations

Columbus

GI Division, Nationwide Children's Hospital, Columbus, Ohio, United States, 43205

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Recipient exclusion criteria
  • * Severe comorbid condition (at discretion of the principal investigator)
  • * On immunosuppressive medications (high dose steroids 30 mg/kg of methylprednisolone)
  • * Severe or fulminant C. difficile colitis
  • * Toxic appearance
  • * Signs of hemodynamic instability
  • * Peritoneal signs on physical exam
  • * Anemia on complete blood count
  • * electrolyte imbalances on basic metabolic panel
  • * Considerations for Increased Risk of Adverse Events Should Be Given to patients with decompensated liver cirrhosis, advanced HIV/acquired immune deficiency syndrome, recent bone marrow transplant, or other cause of severe immunodeficiency.
  • * History of severe anaphylactic shock

Ages Eligible for Study

2 Years to 21 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Jonathan Gisser,

Jonathan M. Gisser, M.D., PRINCIPAL_INVESTIGATOR, Nationwide Children's Hospital

Study Record Dates

2025-01